[Cell Reports Medicine] A bispecific nanobody‒drug conjugate targeting TROP2 and c-Met for low-concentration, single-dose treatment of pancreatic cancer

2026-03-19

[Nature Communications] A selective enrichment and specific probe terminal mediated strategy for highly sensitive detection of microRNAs

2026-03-17

[Nature Communications] XA-Novo: high-throughput mass spectrometry-based de novo sequencing technology for monoclonal antibodies and antibody mixtures

2026-03-14

[Nature Communications] Engineering NIR-II carbon dots through aniline extension with graphene and nitrogen enrichment for hepatobiliary theranostics

2026-03-05

[Nature Communications] Targeting leucine-rich repeat kinase 2 overcomes resistance to oncolytic herpes simplex virus-based therapies in glioblastoma

2026-03-03

[Science Bulletin] Immunogenicity and Safety of an Escherichia coli-produced 9-valent HPV Vaccine in Adolescents Aged 9 to 17 Compared with Young Women

2026-02-28

[Humanities and Social Sciences Communications] The effect of long-term care insurance on labor force participation among informal caregivers: evidence from China

2026-02-26

[Nature Communications] The Crucial but Insufficient Role of E2s Domain’s Residues 490 and 492 in Determining the Host Tropism of Hepatitis E Virus

2026-02-12

[Nature Communications] Assessing HPAI-H5 transmission risk across wild bird migratory flyways in the United States

2026-02-10

A research paper from our school on cervical cancer screening strategies in the post-vaccination era has been selected for the “Editors’ Highlights” of Nature Communications

2026-02-09